Lycia Therapeutics, Inc. funding

Lycia Therapeutics, Inc., a biotechnology company based in South San Francisco, CA, filed a Form D with the SEC on June 25, 2026 and reported $75M raised.

Amount raised$75M

Offering size$75M

Filed with the SECJune 25, 2026

First saleJune 10, 2026

IndustryBiotechnology

SecuritiesEquity

LocationSouth San Francisco, CA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far16

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 25

Other health care rounds in California

Alpfa Medical, Inc.$80.3M · Sep 28Other Health Care BigHat Biosciences, Inc.$75.1M · Oct 26Biotechnology Caspian Therapeutics, Inc.$50M · Sep 23Biotechnology Estuary Biotherapeutics, Inc.$40.7M · Oct 16Biotechnology PFARADIGM Health, Inc.$31.1M · Sep 28Other Health Care Trellis Bioscience, Inc.$22.9M · Oct 21Biotechnology Altay Therapeutics, Inc.$15.7M · Oct 2Biotechnology Adela, Inc.$12M · Oct 19Biotechnology